APOE and Alzheimer disease: It is well known that apolipoprotein E (APOE) ε4 carriers are at a greater risk of AD [32] whereas APOE ε2 carriers are thought to be at lower risk of AD [27] but at a greater risk of CAA–related haemorrhage [18].